ReviewIntestinal research2018
Quality indicators in inflammatory bowel disease.
Review in Intestinal research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 33 citations in OpenAlex.
- Assessing Inflammatory Bowel Disease Care Quality in Portugal: A Nationwide Gastroenterologist Survey.GE Portuguese journal of gastroenterology · 2026Article
- Overcoming Challenges in Electronic Health Record Use in Inflammatory Bowel Disease Care.Gastroenterology & hepatology · 2025Article
- Framework of IBD Care Delivery Across Ages.Journal of Crohn's & colitis · 2024Article
- Challenges and Strategies to Optimising the Quality of Small Bowel Magnetic Resonance Imaging in Crohn's Disease.Diagnostics (Basel, Switzerland) · 2022Review
- Implementation of an Inpatient IBD Service Is Associated with Improvement in Quality of Care and Long-Term Outcomes.Digestive diseases and sciences · 2021Article
- Subjective Needs and Thoughts for the Treatment of Patients with Inflammatory Bowel Disease: Applying Q Methodology.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2021Article
- The Burden of Cost in Inflammatory Bowel Disease: A Medical Economic Perspective and the Future of Value-Based Care.Current gastroenterology reports · 2020Review
- Opioid Use in Patients With Inflammatory Bowel Disease.Crohn's & colitis 360 · 2020Article
- New Zealand National Audit of Outpatient Inflammatory Bowel Disease Standards of Care.Clinical and experimental gastroenterology · 2020Article
- Improving the quality of care for inflammatory bowel disease.Intestinal research · 2019Article
- Quality improvement in healthcare for patients with inflammatory bowel disease.Translational pediatrics · 2019Review
- Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study.World journal of gastroenterology · 2018Article
- Vaccinations in Adult Patients with Inflammatory Bowel Diseases in the West.Inflammatory intestinal diseases · 2018Review
- Medication non-adherence in inflammatory bowel diseases is associated with disability.Intestinal research · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, is a chronic, debilitating, and expensive condition affecting millions of people globally. There is significant variation in the quality of care for patients with IBD across North America, Europe, and Asia; this variation suggests poor quality of care due to overuse, underuse, or misuse of health services and disparity of outcomes. Several initiatives have been developed to reduce variation in care delivery and improve processes of care, patient outcomes, and reduced healthcare costs. These initiatives include the development of quality indicator sets to standardize care across organizations, and learning health systems to enable data sharing between doctors and patients, and sharing of best practices among providers. These programs have been variably successful in improving patient outcomes and reducing healthcare utilization. Further studies are needed to demonstrate the long-term impact and applicability of these efforts in different geographic areas around the world, as regional variations in patient populations, societal preferences, and costs should inform local quality improvement efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.